Case: A Case of pembrolizumab induced myocarditis and complete heart block

Authors

Janak Adhikari, Department of Internal Medicine, Eastern Maine Medical Center, Bangor MEFollow
Priyadarshani Sharma, Department of Internal Medicine, Eastern Maine Medical Center, Bangor ME
Eddy Karnabi, Department of Cardiology, Eastern Maine Medical Center, Bangor, ME
Juan H. Merchan, Department of Cardiology, Eastern Maine Medical Center, Bangor, ME
Hasnain Arshad, Department of Neurology, Eastern Maine Medical Center, Bangor, ME

Abstract

Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.

Recommended Citation

Adhikari, Janak; Sharma, Priyadarshani; Karnabi, Eddy; Merchan, Juan H.; and Arshad, Hasnain (2024) "Case: A Case of pembrolizumab induced myocarditis and complete heart block," Journal of Community Hospital Internal Medicine Perspectives: Vol. 14: Iss. 3, Article 15.
DOI: 10.55729/2000-9666.1329
Available at: https://scholarlycommons.gbmc.org/jchimp/vol14/iss3/15